StockPriceToday

IDEXX Laboratories Inc (IDXX)

IDXX stock price

IDEXX Laboratories Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide.

About IDEXX Laboratories Inc

IDEXX Laboratories Inc. develops, manufactures, and distributes diagnostic products and services for veterinary, livestock, poultry, dairy, and water testing markets worldwide. The company's leadership in veterinary diagnostics has made IDXX stock price sensitive to pet ownership trends and animal health spending patterns.

IDEXX's veterinary diagnostic instruments and consumables enable veterinarians to diagnose diseases and monitor animal health more effectively. The company's point-of-care testing solutions provide rapid results that improve treatment decisions and patient outcomes.

The company's reference laboratory services complement its instrument business while providing comprehensive diagnostic testing for veterinary practices. IDEXX's expansion into telemedicine and digital health solutions demonstrates its commitment to supporting evolving veterinary care needs, influencing IDXX stock price trends.

IDEXX's focus on innovation and customer support has enabled market leadership in veterinary diagnostics while generating consistent profitability. The company's ability to develop new diagnostic capabilities while expanding globally remains important for its continued growth and market valuation.

IDXX Stock 12 Month Chart


Latest News for IDXX

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, Conestoga Capital Advisors Mid Cap ...

Westbrook, Maine-based IDEXX Laboratories, Inc. (IDXX) develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries ...

IDEXX Laboratories, Inc. IDXX posted fourth-quarter 2025 earnings per share (EPS) of $3.08, up 18% year over year. The figure surpassed the Zacks Consensus Estimate by 5.17%. Comparable ...